| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |